Search

everythinglearnresearchcommunity

for

Search:↓

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

New hybrid compound found to effectively prevent hair loss.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Baricitinib may effectively treat lichen planopilaris.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The document concludes that H2-antagonists and proton pump inhibitors are highly effective for ulcers, eradicating Helicobacter pylori is important to prevent recurrence, and misoprostol helps with NSAID-related ulcers.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Finasteride may help treat Neutrophil Actin Dysfunction by reducing LSP1 gene activity.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Adding a second method to PROTACs could improve cancer treatment.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Letrozole may help prevent seizures by reducing certain hormone levels.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.